BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey

Company Hits Construction Milestone for Flagship Manufacturing and R&D Facility in Hopewell BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, is entering a new phase as it continues to build its U.S. presence. The company announced today that the last piece of structural steel … [Read more…]

Sana Announces Partnership with Little Otter — Giving Children and Their Families Access to Quality Mental Health Care

Little Otter is Sana’s first mental health partner focused on treating children’s mental health 85% of Little Otter families saw clinical improvement within 6 weeks of treatment This partnership fills an important health care need for Sana members, expanding access to mental health services for kids 0-14 and support for their families AUSTIN, Texas–(BUSINESS WIRE)–#SMB—Sana, … [Read more…]

New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study

Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–#Afib—Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today announced that use of the … [Read more…]

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the filing of a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) for the proposed initial public offering of Cortigent, Inc. (“Cortigent”). Cortigent, currently a wholly-owned … [Read more…]

Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors

The removal of the age restriction and inclusion of type 2 diabetes will enable more people with diabetes to access Dexcom’s real-time CGM System – the standard of care in diabetes management BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its … [Read more…]

NUCLIDIUM and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNETTM in Neuroendocrine Tumours

BASEL, Switzerland–(BUSINESS WIRE)–NUCLIDIUM today announced that the Neuroendocrine Tumors Research Foundation (“NETRF”) has selected the company and its collaboration partner the University Hospital Basel (Universitätsspital Basel, “USB”) as recipients of its Investigator Award. The grant will support the initiation and execution of a Phase 1 clinical trial with TraceNETTM , a novel copper-based radiodiagnostic for … [Read more…]

RWS Supports Project to Renovate and Modernize the Operating Theatre at The Christian Hospital, Indore

Modern, state-of-the-art facility becomes centre of medical excellence for local community CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, is proud to partner with The Christian Hospital in Indore, India, and help transform its main operating theatre into a modern environment that provides medical excellence to … [Read more…]

Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market

Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and safety assurance than ever before. OXFORD, England–(BUSINESS WIRE)–Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational … [Read more…]

Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer

SINGAPORE–(BUSINESS WIRE)–Prestige Biopharma has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for PBP1510 (International Non-proprietary name: Ulenistamab), in the treatment of unresectable or metastatic pancreatic adenocarcinoma (PDAC) that has relapsed following and/or is refractory to at least one line of prior therapy. PBP1510 targets Pancreatic Adenocarcinoma Upregulated Factor (PAUF), a … [Read more…]

Belmont Village Senior Living and Author Connie Baher Present “An Emotional Survival Guide for Caregivers”

A Webinar Discussion and Q&A Offers Support to Caregivers, Addresses Issues Commonly Faced, and Helpful Strategies for Managing the Challenging Role LA JOLLA, Calif.–(BUSINESS WIRE)–On March 2nd, Belmont Village Senior Living’s Founder and CEO, Patricia Will, moderated a webinar like her book titled “An Emotional Survival Guide for Caregivers.” presented by author Connie Baher. Her … [Read more…]